David Lee
About David Lee
David Lee is the Vice President and Head of Clinical Research at Bristol-Myers Squibb, BMKK, with over 20 years of experience in the pharmaceutical industry across Asia, Europe, and North America.
Professional Background
David Lee is currently the Vice President and Head of Clinical Research at BMKK, Bristol-Myers Squibb. He has amassed over 20 years of experience in the pharmaceutical industry, having worked in diverse regions including Asia, Europe, and North America. His career at Bristol-Myers Squibb includes a previous role as VP and Global Development Lead for Ixempra from 2003 to 2009. Prior to that, he held key positions at Aventis, AstraZeneca, and Zeneca, demonstrating a consistent track record of leading clinical development teams in various therapeutic areas.
Leadership Roles
Throughout his professional journey, David Lee has led numerous high-profile projects and teams. Currently, at Bristol-Myers Squibb, he oversees a team of 50 staff members, which includes Disease Strategy Leads, Study Team Leads, Preclinical and Clinical Pharmacology experts, MDs, and Statisticians. His responsibilities include managing regulatory filings and spearheading clinical research initiatives across multiple geographies. His notable achievements include leading the global development of Ixempra, involving regulatory filings in the US, Europe, Japan, and Asia.
Educational Background
David Lee's extensive educational background underscores his expertise in the pharmaceutical field. He earned an MB.ChB. in Medicine from The University of Glasgow from 1976 to 1981. He then achieved an MRCP from the Royal College of Physicians (UK) in 1985, and an MFPM (UK) from the Faculty of Pharmaceutical Medicine in 1995. Furthering his education, he completed an Executive Development Program at Wharton Business School in 2000, enriching his proficiency in global clinical research leadership.
Experience in Global Product Development
David Lee's experience in global product development is extensive. At Bristol-Myers Squibb, he was the Global Development Lead for Ixempra, guiding the drug through multiple regulatory filings across various continents. His tenure at Aventis as the Global Product Team Leader for Taxotere and his roles at AstraZeneca and Zeneca further highlight his comprehensive expertise in product development across therapeutic areas such as oncology, cardiology, immunology, neuroscience, virology, and cardiovascular/metabolic diseases.
International and Cross-Cultural Leadership
Born in Singapore and trained as a medical doctor in the UK, David Lee brings a unique international perspective to his roles. He has a demonstrated interest in managing and leading teams across different geographical and cultural backgrounds, utilizing his experience gained from his extensive career in Asia, Europe, and North America. His current role in Japan with Bristol-Myers Squibb, in which he has been focusing on clinical research and development for over 3 years, further exemplifies his capability and dedication to fostering international collaboration in clinical research.